Pickleball After Chemo: The Future of Cancer Treatment with Dr. Brandon Mancini

Dr. Peter Crane speaks with radiation oncologist Dr. Brandon Mancini about theranostics, the fusion of diagnostics and therapy using targeted radiopharmaceuticals. Essential listening for cancer patients, oncologists, and anyone interested in the future of precision medicine. ⏱️ Timestamps: 00:00 – Introduction and welcome 00:51 – Dr. Mancini’s background as a radiation oncologist at Banff Health 02:18 – Motivation to enter radiation oncology and personal family story 04:56 – Career pivot to theranostics and training in Germany 08:19 – What is theranostics? Diagnostics + therapy explained 12:27 – Combining with other treatments and ongoing research 14:48 – FAP-targeted therapies and relevance to SFT/sarcomas 18:59 – Banff Health’s programs, FDA-approved treatments, and clinical trials 25:11 – Future directions: alpha emitters, dosing, earlier intervention 32:52 – Outlook for the next decade and reduced reliance on traditional chemo 34:58 – How to learn more and access resources 36:16 – Final thoughts on hope in cancer care 🔗 Resources Mentioned Banff Health: banffhealth.com Pluvicto treatment center locator clinicaltrials.gov (search radioligand therapy and diagnosis) 👍 If this episode helped you, please like, subscribe, and share. It helps these conversations reach the physicians who need them most. #DoctorsMakingADifference #Theranostics #Theragnostics #RareCancer #SolitaryFibrousTumor #PrecisionOncology #BanffHealth #RadioligandTherapy #LivingWithCancer #CancerResearch